Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
MB Venture Partners
AddedFeb 15, 2024
UpdatedJun 28, 2026
MB Venture Partners

MB Venture Partners

Operating

MB Venture Partners: A Tennessee-based venture capital firm focused on life sciences investments.

Location
Memphis, TN, US
Founded
2001
Firm
Compare
Portfolio
Employees
Website

MB Venture Partners is a Tennessee-based venture capital firm that specializes in life sciences investments. The firm typically engages in various stages of funding, including seed, Series A, Series B, and later stages, with a focus on innovative healthcare technologies and medical devices. Their investment size varies across different rounds, supporting companies from early development to more advanced growth stages.

Notable portfolio companies include Anulex Technologies, Applied Spine Technologies, and Axiomed, which have collectively raised significant capital. Key partners at MB Venture Partners bring extensive industry experience and networks, enhancing their ability to support portfolio companies. The firm emphasizes a hands-on investment philosophy, offering strategic guidance and leveraging their expertise to drive growth and innovation in the life sciences sector.

MB Venture Partners - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments56
Current Portfolio Count22
Total Portfolio Exits4

Top Investment Stages

Seed31 (62.0%)
Series B8 (16.0%)
Series A4 (8.0%)
Series C4 (8.0%)
Series D3 (6.0%)

Stage Mix

Seed 62%Series B 16%Series A 8%Series C 8%Series D 6%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Lineus Medical logo

Lineus Medical

SweetBio logo

SweetBio

Spine Wave logo

Spine Wave

Ortho Kinematics logo

Ortho Kinematics

Better Walk logo

Better Walk

EndoInSight logo

EndoInSight

Ecosurg logo

Ecosurg

Blood Monitoring Solutions logo

Blood Monitoring Solutions

Camplex logo

Camplex

Tidal Wave Technology logo

Tidal Wave Technology

Mobilizer logo

Mobilizer

Hapten Sciences logo

Hapten Sciences

iScreen Vision logo

iScreen Vision

BioNanovations logo

BioNanovations

Focal Point Pharmaceuticals logo

Focal Point Pharmaceuticals

Surgilight logo

Surgilight

Spinal Restoration logo

Spinal Restoration

Axiomed logo

Axiomed

Urova Medical logo

Urova Medical

Nanophthalmics logo

Nanophthalmics

HandMinder logo

HandMinder

S2 Interactive logo

S2 Interactive

Veracity Medical Solutions logo

Veracity Medical Solutions

Anulex Technologies logo

Anulex Technologies

Calosyn Pharma logo

Calosyn Pharma

MB Venture Partners - Classification

Also Known As
  • MB Venture Partners LLC
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end